Risperidone antagonism of self-mutilation in a Lesch-Nyhan patient

被引:20
作者
Allen, SM
Rice, SN
机构
[1] North Mississippi Regional Center, Oxford, MS
[2] North Mississippi Regional Center, Oxford, MS 38655
关键词
atypical neuroleptics; Lesch-Nyhan syndrome; risperidone; self-mutilation;
D O I
10.1016/0278-5846(96)00059-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
1. The case is described of a 28-year-old male with a diagnosis of Lesch-Nyhan syndrome. 2. Chronic treatment with the atypical neuroleptic risperidone at 4 mg daily has maintained a significant reduction in occurrence of self-mutilation.
引用
收藏
页码:793 / 800
页数:8
相关论文
共 22 条
[11]   SPROUTING OF STRIATAL SEROTONIN NERVE-TERMINALS FOLLOWING SELECTIVE LESIONS OF NIGRO-STRIATAL DOPAMINE NEURONS IN NEONATAL RAT [J].
LUTHMAN, J ;
BOLIOLI, B ;
TSUTSUMI, T ;
VERHOFSTAD, A ;
JONSSON, G .
BRAIN RESEARCH BULLETIN, 1987, 19 (02) :269-274
[12]   PROPHYLACTIC EFFECT OF L-5-HYDROXYTRYPTOPHAN ON SELF-MUTILATION IN LESCH-NYHAN SYNDROME [J].
MIZUNO, T ;
YUGARI, Y .
NEUROPADIATRIE, 1975, 6 (01) :13-23
[13]   BEHAVIOR IN LESCH-NYHAN SYNDROME [J].
NYHAN, WL .
JOURNAL OF AUTISM AND CHILDHOOD SCHIZOPHRENIA, 1976, 6 (03) :235-252
[14]   ENHANCED ORAL ACTIVITY RESPONSES TO INTRASTRIATAL SKF-38393 AND M-CPP ARE ATTENUATED BY INTRASTRIATAL MIANSERIN IN NEONATAL 6-OHDA-LESIONED RATS [J].
PLECH, A ;
BRUS, R ;
KALBFLEISCH, JH ;
KOSTRZEWA, RM .
PSYCHOPHARMACOLOGY, 1995, 119 (04) :466-473
[15]   INDUCTION OF ORAL DYSKINESIAS IN NAIVE RATS BY D1-STIMULATION [J].
ROSENGARTEN, H ;
SCHWEITZER, JW ;
FRIEDHOFF, AJ .
LIFE SCIENCES, 1983, 33 (25) :2479-2482
[16]  
ROTH BL, 1994, J PHARMACOL EXP THER, V268, P1403
[17]  
SCULLEY DG, 1992, HUM GENET, V90, P195
[18]   ENZYME DEFECT ASSOCIATED WITH A SEX-LINKED HUMAN NEUROLOGICAL DISORDER AND EXCESSIVE PURINE SYNTHESIS [J].
SEEGMILLER, JE ;
ROSENBLOOM, FM ;
KELLEY, WN .
SCIENCE, 1967, 155 (3770) :1682-+
[19]   LESCH-NYHAN SYNDROME - CSF NEUROTRANSMITTER ABNORMALITIES [J].
SILVERSTEIN, FS ;
JOHNSTON, MV ;
HUTCHINSON, RJ ;
EDWARDS, NL .
NEUROLOGY, 1985, 35 (06) :907-911
[20]   IN-VIVO DOPAMINE-D-2 AND SEROTONIN-5-HT2 RECEPTOR-BINDING STUDY OF RISPERIDONE AND HALOPERIDOL [J].
SUMIYOSHI, T ;
KIDO, H ;
SAKAMOTO, H ;
URASAKI, K ;
SUZUKI, K ;
YAMAGUCHI, N ;
MORI, H ;
SHIBA, K ;
YOKOGAWA, K .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 47 (03) :553-557